Bevacizumab, a monoclonal antibody targeting all VEGF-A isoforms, is also useful in platinum-resistant ovarian cancer, suggesting a strong involvement of MC in the tumor [80,81]. The gene discussed is VEGFA; the disease is neoplasm.